Hightide Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in the discovery and development of therapeutics for people suffering from non-viral chronic liver diseases, gastrointestinal diseases and metabolic disorders with large and unsatisfied market needs. The company was founded by Liping Liu in 2011 and is headquartered in Shenzhen, China.